Want to see CH:ALC full AI Analyst Report?

Alcon (ALC) Price & Analysis

19 Followers

ALC Stock Chart & Stats

CHF58.72

-CHF0.06(-0.11%)

At close: Jul 27 4:00 PM EDT

CHF58.72

-CHF0.06(-0.11%)

Day’s Range― - ―

52-Week RangeCHF47.80 - CHF68.34

Previous CloseN/A

Volume1.70M

Average Volume (3M)1.46M

Market Cap

CHF29.34B

Enterprise ValueCHF29.78K

Total Cash (Recent Filing)CHF1.46B

Total Debt (Recent Filing)CHF5.31B

Price to Earnings (P/E)55.9

Beta1.03

Next Earnings

Nov 10, 2026

EPS Estimate

0.71

Next Dividend Ex-DateN/A

Dividend Yield0.48%

Share Statistics

EPS (TTM)1.29

Shares Outstanding499,700,000

10 Day Avg. Volume1,240,075

30 Day Avg. Volume1,456,701

Financial Highlights & Ratios

PEG Ratio39.53

Price to Book (P/B)1.79

Price to Sales (P/S)3.61

P/FCF Ratio21.75

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

CHF71.84

Price Target Upside22.35% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering11

EPS Forecast (FY)2.83

Revenue Forecast (FY)CHF8.97B

Bulls Say, Bears Say

Bulls Say

Broad-based Growth And Market ShareGrowth across Surgical and Vision Care reduces reliance on one product or market. Record contact-lens share, strong UNITY adoption and broad geographic performance support durable customer relationships and recurring demand from procedures and replacement cycles.

Product Innovation Supports Margins And GrowthNew products including TRYPTYR, Valeda, PanOptix Pro and UNITY can expand Alcon’s addressable market and product mix. The raised profitability outlook suggests innovation and scale may support operating leverage beyond a single quarter.

Strong Cash Generation And Conservative LeverageImproving free cash flow provides resources for product development, manufacturing investment and shareholder returns without requiring aggressive borrowing. Low leverage also gives Alcon flexibility to absorb industry volatility and fund long-term expansion.

Bears Say

Recent Profitability And Returns Have WeakenedThe decline in net margin and ROE indicates that recent revenue growth has not translated fully into shareholder returns. If operating costs, pricing pressure or mix issues persist, they could limit the sustainability of projected earnings improvement.

Competition And Slower Surgical AdoptionCompetitive launches and reimbursement-driven adoption challenges can restrain Alcon’s Surgical segment, where equipment placements and implant volumes support recurring consumables. Persistent pressure could weaken growth and reduce operating leverage in this strategic business.

Pipeline Execution SetbacksThe PowerVision discontinuation removes a potential long-term innovation pathway, while UNITY DX delays defer expected revenue and adoption benefits. Together, these issues show that clinical validation and scalable manufacturing remain execution risks for the pipeline.

Alcon News

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Gorilla Technology Group Inc...

3d ago

ALC

DIA

Alcon price target raised to CHF 73 from CHF 70 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Alcon (ALC) to CHF 73 from CHF 70 and keeps...

10d ago

ALC

Alcon price target raised to $78.40 from $77.53 at JPMorgan

JPMorgan raised the firm’s price target on Alcon (ALC) to $78.40 from $77.53 and keeps a Neutral rating...

11d ago

ALC

Alcon price target raised to $85 from $80 at Mizuho

Mizuho analyst Anthony Petrone raised the firm’s price target on Alcon (ALC) to $85 from $80 and keeps...

11d ago

ALC

Alcon price target raised to CHF 63.50 from CHF 62.80 at JPMorgan

JPMorgan raised the firm’s price target on Alcon (ALC) to CHF 63.50 from CHF 62.80 and keeps a...

11d ago

ALC

Alcon downgraded to Neutral from Outperform at BNP Paribas

BNP Paribas downgraded Alcon (ALC) to Neutral from Outperform with a $79 price target The firm sees a...

11d ago

ALC

Pershing Square Inc. reports Netflix, Visa among six new investments

Pershing Square Inc. (PS) said in its quarterly letter to investors: “We recently made new investments in Visa...

11d ago

Five Below upgraded, StubHub downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

11d ago

ALC

Lensar price target raised to $13 from $10 at Lake Street

Lake Street analyst Frank Takkinen raised the firm’s price target on Lensar (LNSR) to $13 from $10 and...

11d ago

ALC

LNSR

Morning Movers: On Holding slips following quarterly results

Stock futures are modestly higher as investors look ahead to Wednesday’s July consumer-price report, while developments surrounding the...

16d ago

ALC

Alcon Earnings Call Highlights Growth, Margins and Pipeline

Alcon (($CH:ALC)) has held its Q2 earnings call. Read on for the main highlights of the call. Alcon’s...

16d ago

ALC

Analyst Reiterates Buy on Alcon After Q2 Beat, Raised Earnings Outlook, and Strengthening Multi-Pillar Growth Drivers

David Saxon, an analyst from Needham, reiterated the Buy rating on Alcon. The associated price target is $95.00....

17d ago

ALC

Alcon Lifts 2026 Guidance After Strong Q2 Eye-Care Growth

An announcement from Alcon ( ($CH:ALC) ) is now available. Alcon reported second-quarter 2026 results on August 10,...

17d ago

ALC

ALC Earnings this Week: How Will it Perform?

Alcon (ALC) is scheduled to report 2nd quarter earnings on 08/10/2026, after the market closes. Regarding Q2 estimates,...

20d ago

ALC

ALC FAQ

What was Alcon Inc’s price range in the past 12 months?

Alcon Inc lowest stock price was CHF47.80 and its highest was CHF68.34 in the past 12 months.

What is Alcon Inc’s market cap?

Alcon Inc’s market cap is CHF29.34B.

When is Alcon Inc’s upcoming earnings report date?

Alcon Inc’s upcoming earnings report date is Nov 10, 2026 which is in 74 days.

How were Alcon Inc’s earnings last quarter?

Alcon Inc released its earnings results on Aug 10, 2026. The company reported CHF0.681 earnings per share for the quarter, beating the consensus estimate of CHF0.604 by CHF0.077.

Is Alcon Inc overvalued?

According to Wall Street analysts Alcon Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Alcon Inc pay dividends?

Alcon Inc pays a Annually dividend of CHF0.28 which represents an annual dividend yield of 0.48%. See more information on Alcon Inc dividends here

What is Alcon Inc’s EPS estimate?

Alcon Inc’s EPS estimate is 0.71.

How many shares outstanding does Alcon Inc have?

Alcon Inc has 499,700,000 shares outstanding.

What happened to Alcon Inc’s price movement after its last earnings report?

Alcon Inc reported an EPS of CHF0.681 in its last earnings report, beating expectations of CHF0.604. Following the earnings report the stock price went up 4.698%.

Which hedge fund is a major shareholder of Alcon Inc?

Currently, no hedge funds are holding shares in CH:ALC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Alcon Stock Smart Score

Outperform

Fundamentals

Return on Equity

0.48%

Trailing 12-Months

Asset Growth

-0.92%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Alcon Inc

Alcon Inc. is a global eye care enterprise dedicated to the research, development, manufacturing, and distribution of a comprehensive range of vision products for both eye care professionals and their patients worldwide. The company operates through two primary divisions. Its Surgical segment equips ophthalmic surgeons with advanced solutions for various procedures. This includes specialized equipment, diagnostic instrumentation, and implantable devices such as intraocular lenses (IOLs), alongside a full suite of consumables like viscoelastic substances, surgical solutions, and customized procedure kits. For cataract interventions, key offerings feature the Centurion Vision System, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA System for intra-operative measurements. Vitreoretinal surgeons benefit from systems like Constellation Vision, procedure packs, lasers, and a variety of specialized micro-instruments, including grieshaber and MIVS tools, scissors, forceps, medical-grade vitreous tamponades, and Hypervit vitrectomy probes. Refractive surgery innovations include WaveLight lasers and Contoura Vision for LASIK treatments, and the segment also provides the EX-PRESS glaucoma filtration device. Its IOL portfolio, prominently featuring AcrySof IQ, includes advanced technology lenses like PanOptix and ReSTOR, designed to correct presbyopia and astigmatism during cataract removal. The Vision Care segment addresses everyday eye health needs. It offers a diverse selection of contact lenses, including daily disposables, reusable options, and color-enhancing varieties. This segment also provides ocular health products for conditions such as dry eye, glaucoma, and allergies, in addition to contact lens care solutions, ocular vitamins, and redness-relieving drops. Prominent brands within this segment include TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux. Founded in 1945, the company was initially known as Alcon Universal S.A. before rebranding as Alcon Inc. in December 2001. Its headquarters are located in Geneva, Switzerland.

Alcon (ALC) Earnings & Revenues

Historic Earnings Reports

ALC Company Deck

ALC Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call conveyed a clearly positive operational and financial quarter: 7% consolidated sales growth, strong equipment performance (UNITY), margin expansion (+250 bps gross margin, +160 bps operating margin), EPS and cash-flow strength, and multiple successful new-product introductions (PanOptix Pro, TRYPTYR, Valeda). Notable negatives included the discontinuation of the PowerVision accommodating IOL program, slower growth in implantables and certain glaucoma products, a few one-time margin items and manufacturability timing for UNITY DX. On balance, the positives — consistent revenue and margin expansion, robust cash generation and multiple high-potential product rollouts and market-share gains — outweigh the setbacks.View all CH:ALC earnings summaries

ALC Stock 12 Month Forecast

Average Price Target

CHF71.84

▲(22.35% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"47":"CHF47","86":"CHF86","56.75":"CHF56.8","66.5":"CHF66.5","76.25":"CHF76.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF85.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":71.8417407398,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF71.84</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":48,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF48.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[47,56.75,66.5,76.25,86],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.38,57.65846153846154,59.93692307692308,62.215384615384615,64.49384615384615,66.77230769230769,69.05076923076923,71.32923076923078,73.6076923076923,75.88615384615385,78.16461538461539,80.44307692307692,82.72153846153846,{"y":85,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.38,56.64628774921539,57.91257549843077,59.178863247646156,60.44515099686154,61.71143874607692,62.97772649529231,64.2440142445077,65.51030199372308,66.77658974293847,68.04287749215385,69.30916524136923,70.57545299058462,{"y":71.8417407398,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.38,54.8123076923077,54.244615384615386,53.67692307692308,53.10923076923077,52.541538461538465,51.973846153846154,51.40615384615385,50.83846153846154,50.27076923076923,49.70307692307692,49.135384615384616,48.567692307692305,{"y":48,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":71.472,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.71,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.132,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.51,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.431,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.974,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.66,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.024,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.789,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.938,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.72,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.78,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.38,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >